Evidence map›Paper›PMID 32307594›Full record

ArticleEJNMMI research2020

Visual and quantitative evaluation of [

Lemonitsa H Mammatas, Clasina M Venema, Carolina P Schröder, Henrica C W de Vet, Michel van Kruchten, Andor W J M Glaudemans, Maqsood M Yaqub, Henk M W Verheul, Epie Boven, Bert van der Vegt and 5 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01988324 (Androgen Receptor and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01988324 phase2completednot on this map

Androgen Receptor and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients

TypeinterventionalSponsorUniversity Medical Center GroningenRan2014 to 2015Enrolled24ConditionsMetastatic Breast CancerArmsFDHT-PET scan, FES-PET scan, CT-scan, Bone scintigraphy, Tumor biopsy
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Role of Estrogen Receptor-Targeted PET with 16α-Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Pooled it
  2. Review
  3. [Diagnostics (Basel, Switzerland) · 2023
    Review
  4. Diagnostic effectiveness of [European journal of nuclear medicine and molecular imaging · 2023
    Article
  5. Review
  6. The Role of PET/CT in Breast Cancer.Diagnostics (Basel, Switzerland) · 2023
    Review
  7. Review
  8. Review
  9. [Oncotarget · 2021
    Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lemonitsa H MammatasDepartment of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Clasina M VenemaDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.
Carolina P SchröderDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.
Henrica C W de VetDepartment of Epidemiology and Biostatistics, Amsterdam Public Health Institute, Amsterdam UMC, VUmc University Medical Center Amsterdam, De Boelelaan 1105, 1081, HV, Groningen, The Netherlands.
Michel van KruchtenDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.
Andor W J M GlaudemansDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.
Maqsood M YaqubDepartment of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Henk M W VerheulDepartment of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Epie BovenDepartment of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Bert van der VegtDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, DHanzeplein 1, 9713, GZ, Groningen, The Netherlands.
Erik F J de VriesDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.
Elisabeth G E de VriesDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.
Otto S HoekstraDepartment of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Geke A P HospersDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.
C Willemien Menke-van der Houven van OordtDepartment of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands. c.menke@amsterdamumc.nl.

Funding

Center for Translational Molecular Medicine 2012-2708
6 · The paper itself

Abstract

purposeCorrect identification of tumour receptor status is important for treatment decisions in breast cancer. [

methodsIn this prospective, two-centre study, patients with ER-positive metastatic breast cancer underwent both [

resultsVisual analysis showed an absolute positive and negative interobserver agreement for [

conclusionVisual and quantitative evaluation of [

trial registrationClinicalTrials.gov, NCT01988324. Registered 20 November 2013, https://clinicaltrials.gov/ct2/show/NCT01988324?term=FDHT+PET&draw=1&rank=2.

Indexed as

Androgen receptorBreast cancerFDHT PETFES PETInterobserver variabilityOestrogen receptor

Identifiers

PMID32307594
PMCPMC7167394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.